BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 25, 2019
View Archived Issues
Tipping the scales against p53 mutations
Read More
Blocking neurogenesis ineffective against chronic seizures
Read More
Oral anti-CD3 (OKT-3) results in immunologic changes in patients with ulcerative colitis
Read More
Regeneron studies REGN-5678 with cemiplimab in metastatic castration-resistant prostate cancer
Read More
Merck & Co. presents clinical data for MK-8591 in patients with HIV-1 infection
Read More
First subject enrolled in phase III ONSET-2 study of OC-01 nasal spray
Read More
Patient enrollment ongoing in phase I study of SEL-120 in patients with AML or HR-MDS
Read More
Synthorx initiates first-in-human HAMMER study of THOR-707
Read More
SRI-011381 is neuroprotective and improves cognition in vivo
Read More
Preliminary phase I data for the long-acting HIV capsid inhibitor GS-6207
Read More
Novel p53 gene therapy increases efficacy of cabazitaxel in prostate carcinoma models
Read More
Orion's OB-002 shown to be more potent than maraviroc in a model of HIV infection
Read More
Brain drain may hold key to treating neurodegenerative diseases
Read More
King Saud University discovers new calcium channel blockers
Read More
Wuxi Advant Biotechnology identifies NUDT1 inhibitors
Read More
New CSF-1 receptor inhibitors described by Medshine Discovery
Read More
Guangzhou Henovcom Bioscience patents MAP3K5 inhibitors
Read More
HitGen describes stimulator of interferon genes protein agonists
Read More
CR3 is a potential therapeutic target for treating Neisseria gonorrhoeae infection
Read More
Exscientia announces collaboration with Rallybio for development of rare disease therapeutics
Read More
Daewoong initiates phase II study of DWP-16001 in type 2 diabetes
Read More
FDA approves Baqsimi to treat severe hypoglycemia
Read More
CEPI funding to support Valneva's late-stage development of chikungunya vaccine
Read More
Scynexis reaches SPA agreement with FDA on phase III study of ibrexafungerp to prevent recurrent VVC
Read More
BioHaven opens enrollment in phase III study of BHV-3241 for multiple system atrophy
Read More
REGENXBIO adds new HAE program to pipeline, collaborates with Neurimmune
Read More